Dr Mark Campion Clawson, MD | |
901 N Curtis Rd, Suite 304, Boise, ID 83706-1338 | |
(208) 342-4263 | |
(208) 375-0597 |
Full Name | Dr Mark Campion Clawson |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 901 N Curtis Rd, Boise, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174572697 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0106X | Orthopaedic Surgery - Hand Surgery | M5840 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mark Campion Clawson, MD 901 N Curtis Rd, Suite 304, Boise, ID 83706-1338 Ph: (208) 342-4263 | Dr Mark Campion Clawson, MD 901 N Curtis Rd, Suite 304, Boise, ID 83706-1338 Ph: (208) 342-4263 |
News Archive
Atlanta Vascular Research Foundation (AVRF), together with its collaborators at the University of Prince Edward Island (UPEI), has been awarded an Innovation PEI Pilot and Discovery Fund grant by Innovation PEI. The grant is to continue research and development in combining nutraceuticals to magnify clinical benefits for the prevention and treatment of cardiovascular and metabolic diseases. The funding from this grant is $25,000.
Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2010.
Researchers at the University of Calgary and The Hospital for Sick Children (SickKids), in Toronto, have discovered genetic risk factors for OCD that could help pave the way for earlier diagnosis and improved treatment for children and youth.
Researchers in the University of Georgia's Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
› Verified 8 days ago
Tracye Jean-marie Lawyer, MD, PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8950 W Emerald St Ste 168, Boise, ID 83704 Phone: 208-321-1209 Fax: 208-321-1211 | |
Dustin I Judd, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Robbins Rd, Suite 100, Boise, ID 83702 Phone: 208-383-0201 | |
Dr. Michael Glover, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 500 W Fort St, Mail Code #112, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1082 | |
Jeffrey D Smith, PA C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7979 W Rifleman St, Boise, ID 83704 Phone: 208-989-0598 | |
Howard A King, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 N Robbins Rd, Ste 100, Boise, ID 83702 Phone: 208-383-0201 Fax: 208-489-4300 | |
Dr. Jeffrey Glenn Hessing, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8854 W Emerald St, Suite 140, Boise, ID 83704 Phone: 208-327-4790 Fax: 208-367-4888 | |
Dr. Kirk J Lewis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1188 University Dr, Boise, ID 83706 Phone: 208-336-8250 Fax: 208-345-9514 |